6,029 filings
Page 2 of 100
6-K
GSK
GSK Plc
2 Apr 24
Total Voting Rights
1:17pm
SC 13D/A
NKTX
Nkarta Inc
28 Mar 24
Nkarta / GSK ownership change
5:06pm
6-K
GSK
GSK Plc
26 Mar 24
Director/pdmr Shareholding
7:45am
F-3ASR
Glaxosmithkline Capital Inc
25 Mar 24
Automatic shelf registration (foreign)
2:01pm
6-K
GSK
GSK Plc
25 Mar 24
Notice of Agm
9:38am
6-K
GSK
GSK Plc
22 Mar 24
Transfer of Treasury Shares
12:48pm
6-K
GSK
GSK Plc
22 Mar 24
Director/pdmr Shareholding
12:17pm
6-K
GSK
GSK Plc
18 Mar 24
New Phase III Jemperli Data In Endometrial Cancer
9:56am
6-K
GSK
GSK Plc
13 Mar 24
Director/pdmr Shareholding
1:15pm
6-K
GSK
GSK Plc
8 Mar 24
Board Committee Change
12:48pm
6-K
GSK
GSK Plc
7 Mar 24
GSK Announces Positive Blenrep DREAMM-8 Results
6:13am
6-K
GSK
GSK Plc
6 Mar 24
VIIV Lai VS Oral Soc Data In Adherence-challenged
11:11am
6-K
GSK
GSK Plc
5 Mar 24
GSK Annual Report 2023 on Form 20 F
1:09pm
IRAN
GSK
GSK Plc
5 Mar 24
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
12:30pm
20-F
2023 FY
GSK
GSK Plc
Annual report (foreign)
5 Mar 24
12:10pm
6-K
GSK
GSK Plc
5 Mar 24
New VIIV La Formulation Potential 4-MONTH Dosing
6:10am
6-K
GSK
GSK Plc
1 Mar 24
Total Voting Rights
10:29am
6-K
GSK
GSK Plc
1 Mar 24
GSK Publishes Annual Report 2023
9:55am
6-K
GSK
GSK Plc
29 Feb 24
Directorate Change
6:27am
6-K
GSK
GSK Plc
29 Feb 24
Statement: Zantac (Ranitidine) Litigation
6:27am